USPTO serial 87560157
PROTEINEX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 6, 2018
- Examiner
- GILLES, DEBORAH LYNN MEINERS
- Law office
- TMO LAW OFFICE 110
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with PROTEINEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
LLORENS PHARMACEUTICAL INTERNATIONAL DIVISION
Miami, FL
Other trademarks owned by LLORENS PHARMACEUTICAL INTERNATIONAL DIVISION
LLORENS PHARMACEUTICAL INTERNATIONAL DIVISION
Miami, FL
Other trademarks owned by LLORENS PHARMACEUTICAL INTERNATIONAL DIVISION
LLORENS PHARMACEUTICAL INTERNATIONAL DIVISION
Miami, FL
Other trademarks owned by LLORENS PHARMACEUTICAL INTERNATIONAL DIVISION
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Armando Llorens
Armando Llorens FURGANG & ADWAR, LLP1325 AVENUE OF THE AMERICAS, 28TH FLOORNEW YORK, NY 10019UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Liquid nutritional supplement containing protein; Powdered nutritional supplement concentrate containing protein | ACTIVE | Jan 1, 1998 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LLORENS PHARMACEUTICAL INTERNATIONAL DIVISION
- Other trademarks owned by LLORENS PHARMACEUTICAL INTERNATIONAL DIVISION
- Other trademarks owned by LLORENS PHARMACEUTICAL INTERNATIONAL DIVISION
- Other trademarks in Class 005
- Similar marks named PROTEINEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 28, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Feb 28, 2024 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Feb 28, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 11, 2023 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Mar 6, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 6, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 19, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 19, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 29, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 5, 2017 | ALIE | ASSIGNED TO LIE | — |
| Oct 24, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 24, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 24, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 24, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 24, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 23, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 10, 2017 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 18, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 18, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 14, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 11, 2017 | NWAP | NEW APPLICATION ENTERED | — |